Identifying and Quantifying Mutagenic Impurities in Pharmaceutical Products

Article

LCGC E-Books

LCGC E-BooksLCGC E-Books-07-20-2020
Issue 17
Pages: 17–26

Meeting detection challenges presented by nitrosamine impurities Determination of NDMA and nitrosamine impurities using triple-quadrupole LC/MS Determination of genotoxic impurities in ranitidine APIs and drug products

Related Content